Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment

Radiotherapy (RT) is an important therapeutic option in patients with localized prostate cancer (PC). Unfortunately, radiation treatment causes a decrease in peripheral lymphocytes and, consequently, influences the patients’ immune status. Our aim was to study changes in peripheral blood immune cell...

Full description

Bibliographic Details
Main Authors: Fiorella D’Auria, Teodora Statuto, Luciana Rago, Antonietta Montagna, Giovanni Castaldo, Irene Schirò, Anna Zeccola, Teresa Virgilio, Gabriella Bianchino, Antonio Traficante, Alessandro Sgambato, Vincenzo Fusco, Luciana Valvano, Giovanni Calice
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.829812/full
_version_ 1828200341173174272
author Fiorella D’Auria
Teodora Statuto
Luciana Rago
Antonietta Montagna
Giovanni Castaldo
Irene Schirò
Anna Zeccola
Teresa Virgilio
Gabriella Bianchino
Antonio Traficante
Alessandro Sgambato
Vincenzo Fusco
Luciana Valvano
Giovanni Calice
author_facet Fiorella D’Auria
Teodora Statuto
Luciana Rago
Antonietta Montagna
Giovanni Castaldo
Irene Schirò
Anna Zeccola
Teresa Virgilio
Gabriella Bianchino
Antonio Traficante
Alessandro Sgambato
Vincenzo Fusco
Luciana Valvano
Giovanni Calice
author_sort Fiorella D’Auria
collection DOAJ
description Radiotherapy (RT) is an important therapeutic option in patients with localized prostate cancer (PC). Unfortunately, radiation treatment causes a decrease in peripheral lymphocytes and, consequently, influences the patients’ immune status. Our aim was to study changes in peripheral blood immune cell subpopulations after RT and during 6 months’ follow-up in 2 groups of PC patients irradiated with different techniques and dose fractions with curative intent. We also investigated the presence of correlation between immune cell modulation and genitourinary or gastrointestinal toxicity. We enrolled 44 patients treated with curative RT (RapidArc/hypofractionation regimen or 3D conformal/conventional fractionation) for localized PC. Total white blood cell (WBC), absolute lymphocyte counts (ALCs), and peripheral immune cell subpopulations were analyzed at baseline, at the end of RT, and 3 and 6 months after the end of RT. WBC and ALC greatly decreased at the end of RT with a trend to recover at 6 months’ follow-up in the hypofractionation group but not in the conventional one. Furthermore, B, total T, T CD4+, T CD8+, and NK cell values dropped significantly in both groups at the end of RT, with a minor decrease detectable in the hypofractionation group for B, total T, and T CD4+ lymphocytes with respect to the other technique/fractionation group. Double-negative T (DNT), double-positive T (DPT), and NKT cells significantly decreased at the end of RT with a slight tendency to recover values during follow-up, particularly in the hypofractionation group. No correlation with genitourinary or gastrointestinal toxicity was found. In this study, we showed, for the first time, the effects of RapidArc/moderate hypofractionation RT on immune cell subsets in patients treated for localized PC. Due to the growing interest in minority T-cell subpopulations for immunotherapy, we also reported longitudinal monitoring of the effects of RT on DNT, DPT, and NKT, which was never studied before. Our preliminary data highlight the importance of considering the effects of different RT techniques/fractionation regimens on peripheral immune cells, in the era of RT and immunotherapy combination.
first_indexed 2024-04-12T11:11:35Z
format Article
id doaj.art-b51605b4adc94411a52faf8538e17f23
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T11:11:35Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b51605b4adc94411a52faf8538e17f232022-12-22T03:35:36ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-06-011210.3389/fonc.2022.829812829812Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation TreatmentFiorella D’Auria0Teodora Statuto1Luciana Rago2Antonietta Montagna3Giovanni Castaldo4Irene Schirò5Anna Zeccola6Teresa Virgilio7Gabriella Bianchino8Antonio Traficante9Alessandro Sgambato10Vincenzo Fusco11Luciana Valvano12Giovanni Calice13Laboratory of Clinical Pathology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyLaboratory of Clinical Research and Advanced Diagnostics, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyLaboratory of Clinical Pathology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyLaboratory of Clinical Pathology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyScientific Direction, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyLaboratory of Clinical Research and Advanced Diagnostics, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyLaboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, ItalyRadiotherapy (RT) is an important therapeutic option in patients with localized prostate cancer (PC). Unfortunately, radiation treatment causes a decrease in peripheral lymphocytes and, consequently, influences the patients’ immune status. Our aim was to study changes in peripheral blood immune cell subpopulations after RT and during 6 months’ follow-up in 2 groups of PC patients irradiated with different techniques and dose fractions with curative intent. We also investigated the presence of correlation between immune cell modulation and genitourinary or gastrointestinal toxicity. We enrolled 44 patients treated with curative RT (RapidArc/hypofractionation regimen or 3D conformal/conventional fractionation) for localized PC. Total white blood cell (WBC), absolute lymphocyte counts (ALCs), and peripheral immune cell subpopulations were analyzed at baseline, at the end of RT, and 3 and 6 months after the end of RT. WBC and ALC greatly decreased at the end of RT with a trend to recover at 6 months’ follow-up in the hypofractionation group but not in the conventional one. Furthermore, B, total T, T CD4+, T CD8+, and NK cell values dropped significantly in both groups at the end of RT, with a minor decrease detectable in the hypofractionation group for B, total T, and T CD4+ lymphocytes with respect to the other technique/fractionation group. Double-negative T (DNT), double-positive T (DPT), and NKT cells significantly decreased at the end of RT with a slight tendency to recover values during follow-up, particularly in the hypofractionation group. No correlation with genitourinary or gastrointestinal toxicity was found. In this study, we showed, for the first time, the effects of RapidArc/moderate hypofractionation RT on immune cell subsets in patients treated for localized PC. Due to the growing interest in minority T-cell subpopulations for immunotherapy, we also reported longitudinal monitoring of the effects of RT on DNT, DPT, and NKT, which was never studied before. Our preliminary data highlight the importance of considering the effects of different RT techniques/fractionation regimens on peripheral immune cells, in the era of RT and immunotherapy combination.https://www.frontiersin.org/articles/10.3389/fonc.2022.829812/fullprostate cancerradiotherapyconventional fractionationperipheral immune cellstoxicityhypofractionation
spellingShingle Fiorella D’Auria
Teodora Statuto
Luciana Rago
Antonietta Montagna
Giovanni Castaldo
Irene Schirò
Anna Zeccola
Teresa Virgilio
Gabriella Bianchino
Antonio Traficante
Alessandro Sgambato
Vincenzo Fusco
Luciana Valvano
Giovanni Calice
Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
Frontiers in Oncology
prostate cancer
radiotherapy
conventional fractionation
peripheral immune cells
toxicity
hypofractionation
title Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
title_full Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
title_fullStr Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
title_full_unstemmed Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
title_short Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
title_sort modulation of peripheral immune cell subpopulations after rapidarc moderate hypofractionated radiotherapy for localized prostate cancer findings and comparison with 3d conformal conventional fractionation treatment
topic prostate cancer
radiotherapy
conventional fractionation
peripheral immune cells
toxicity
hypofractionation
url https://www.frontiersin.org/articles/10.3389/fonc.2022.829812/full
work_keys_str_mv AT fiorelladauria modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT teodorastatuto modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT lucianarago modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT antoniettamontagna modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT giovannicastaldo modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT ireneschiro modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT annazeccola modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT teresavirgilio modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT gabriellabianchino modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT antoniotraficante modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT alessandrosgambato modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT vincenzofusco modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT lucianavalvano modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment
AT giovannicalice modulationofperipheralimmunecellsubpopulationsafterrapidarcmoderatehypofractionatedradiotherapyforlocalizedprostatecancerfindingsandcomparisonwith3dconformalconventionalfractionationtreatment